TY - JOUR
T1 - Prolonged Opioid Use and Pain Outcome and Associated Factors after Surgery under General Anesthesia
T2 - A Prospective Cohort Association Multicenter Study
AU - Kuck, Kai
AU - Naik, Bhiken I.
AU - Domino, Karen B.
AU - Posner, Karen L.
AU - Saager, Leif
AU - Stuart, Ami R.
AU - Johnson, Ken B.
AU - Alpert, Salome B.
AU - Durieux, Marcel E.
AU - Sinha, Anik K.
AU - Brummett, Chad M.
AU - Aziz, Michael F.
AU - Cummings, Kenneth C.
AU - Gaudet, John G.
AU - Kurz, Andrea
AU - Rijsdijk, Mienke
AU - Wanderer, Jonathan P.
AU - Pace, Nathan L.
AU - Berman, Mitchell F.
AU - Corradini, Beatriz Raposo
AU - Mincer, Shawn L.
AU - Rose, Sydney E.
AU - Van Klei, Wilton A.
AU - Edwards, David A.
AU - Lamers, Olivia O.A.
AU - Vaughn, Michelle T.
N1 - Funding Information:
This research was supported in part through computational resources and services provided by Advanced Research Computing, a division of Information and Technology Services at the University of Michigan (Ann Arbor, Michigan). Additionally, the authors thank the following people whose hard work on this project made it possible: Marcia E. Birk, R.N., Anesthesiology, University of Virginia, Charlottesville, Virginia; Amber D. Bledsoe, M.D., Anesthesiology, University of Utah, Salt Lake City, Utah; Jacqueline F. van Dijk, Ph.D., Anesthesiology, University Medical Center Utrecht, Utrecht, Netherlands; Lisa Y. Flint, B.S., Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington; Alexander F. Friend, M.S., Anesthesiology, University of Vermont, Burlington, Vermont; Scott R. Junkins, M.D., Anesthesiology, University of Utah, Salt Lake City, Utah; Yuri Kida, M.S.W., Anesthesiology, University of Utah, Salt Lake City, Utah; Sherry L. McKinnon, M.S., Anesthesiology, Washington University, St. Louis, Missouri; Jordan Oberhaus, B.S., Anesthesiology, Washington University, St. Louis, Missouri; Nicole A. Pescatore, M.P.H., Anesthesiology, University of Michigan, Ann Arbor, Michigan; Julia L. White, B.S., Anesthesiology, University of Utah, Salt Lake City, Utah; Troy S. Wildes, M.D., Anesthesiology, Washington University School of Medicine, St. Louis, Missouri; and Josh Zimmerman, M.D., Anesthesiology, University of Utah, Salt Lake City, Utah.
Funding Information:
Dr. Brummett reports being a consultant for Heron Therapeutics (San Diego, California), Vertex Pharmaceuticals (Boston, Massachusetts), Benter Foundation (Pittsburgh, Pennsylvania), and Alosa Health (Boston, Massachusetts), and providing expert medical malpractice testimony. Dr. Domino declares no competing interests. She reports research funding to the institution provided by Mathematica (Princeton, New Jersey) and Edwards Lifesciences (Irvine, California), unrelated to this project. Dr. Johnson declares no competing interests. He reports research funding unrelated to this work from Medtronic (Dublin, Ireland) and the National Institute of Neurologic Disorders and Strokes (Bethesda, Maryland). He also reports being an equity partner in Applied Medical Visualizations, L.L.C. (Salt Lake City, Utah), also unrelated to this work. Dr. Kuck declares no competing interests. He reports research funding, unrelated to this work, from the National Science Foundation (Alexandria, Virginia), Foundation for Anesthesia Education and Research (Schaumburg, Illinois), National Institute of General Medical Sciences (Bethesda, Maryland), Dynasthetics L.L.C. (West Valley City, Utah), and Medtronic. He also reports equity interest, unrelated to this work, in KSCube, L.L.C. (Park City, Utah), and CKC Medical, L.L.C. (Park City, Utah), and financial interest, unrelated to this work, from patents assigned to Drägerwerk (Lübeck, Germany) and the University of Utah Research Foundation (Salt Lake City, Utah). Dr. Posner declares no competing interests. She reports research funding, unrelated to this work, to the institution provided by Mathematica, Microsoft Research (Seattle, Washington), American Society of Anesthesiologists (Schaumburg, Illinois), Society for Anesthesia and Sleep Medicine (Milwaukee, Wisconsin), Anesthesia Patient Safety Foundation (Schaumburg, Illinois), and Anesthesia Quality Institute (Schaumburg, Illinois); and travel and speaker funding, unrelated to this work, to the author from The Doctors Company (Napa, California). Dr. Saager declares no competing interests. He reports receiving funding, unrelated to this work, from The Surgical Company International (Amersfoort, Netherlands). Dr. Pace declares no competing interests. He reports receiving funding, unrelated to this work, from Elute Inc. (Salt Lake City, Utah). The other authors declare no competing interests.
Publisher Copyright:
Copyright © 2023, the American Society of Anesthesiologists. All Rights Reserved.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Background: There is insufficient prospective evidence regarding the relationship between surgical experience and prolonged opioid use and pain. The authors investigated the association of patient characteristics, surgical procedure, and perioperative anesthetic course with postoperative opioid consumption and pain 3 months postsurgery. The authors hypothesized that patient characteristics and intraoperative factors predict opioid consumption and pain 3 months postsurgery. Methods: Eleven U.S. and one European institution enrolled patients scheduled for spine, open thoracic, knee, hip, or abdominal surgery, or mastectomy, in this multicenter, prospective observational study. Preoperative and postoperative data were collected using patient surveys and electronic medical records. Intraoperative data were collected from the Multicenter Perioperative Outcomes Group database. The association between postoperative opioid consumption and surgical site pain at 3 months, elicited from a telephone survey conducted at 3 months postoperatively, and demographics, psychosocial scores, pain scores, pain management, and case characteristics, was analyzed. Results: Between September and October 2017, 3,505 surgical procedures met inclusion criteria. A total of 1,093 cases were included; 413 patients were lost to follow-up, leaving 680 (64%) for outcome analysis. Preoperatively, 135 (20%) patients were taking opioids. Three months postsurgery, 96 (14%) patients were taking opioids, including 23 patients (4%) who had not taken opioids preoperatively. A total of 177 patients (27%) reported surgical site pain, including 45 (13%) patients who had not reported pain preoperatively. The adjusted odds ratio for 3-month opioid use was 18.6 (credible interval, 10.3 to 34.5) for patients who had taken opioids preoperatively. The adjusted odds ratio for 3-month surgical site pain was 2.58 (1.45 to 4.4), 4.1 (1.73 to 8.9), and 2.75 (1.39 to 5.0) for patients who had site pain preoperatively, knee replacement, or spine surgery, respectively. Conclusions: Preoperative opioid use was the strongest predictor of opioid use 3 months postsurgery. None of the other variables showed clinically significant association with opioid use at 3 months after surgery.
AB - Background: There is insufficient prospective evidence regarding the relationship between surgical experience and prolonged opioid use and pain. The authors investigated the association of patient characteristics, surgical procedure, and perioperative anesthetic course with postoperative opioid consumption and pain 3 months postsurgery. The authors hypothesized that patient characteristics and intraoperative factors predict opioid consumption and pain 3 months postsurgery. Methods: Eleven U.S. and one European institution enrolled patients scheduled for spine, open thoracic, knee, hip, or abdominal surgery, or mastectomy, in this multicenter, prospective observational study. Preoperative and postoperative data were collected using patient surveys and electronic medical records. Intraoperative data were collected from the Multicenter Perioperative Outcomes Group database. The association between postoperative opioid consumption and surgical site pain at 3 months, elicited from a telephone survey conducted at 3 months postoperatively, and demographics, psychosocial scores, pain scores, pain management, and case characteristics, was analyzed. Results: Between September and October 2017, 3,505 surgical procedures met inclusion criteria. A total of 1,093 cases were included; 413 patients were lost to follow-up, leaving 680 (64%) for outcome analysis. Preoperatively, 135 (20%) patients were taking opioids. Three months postsurgery, 96 (14%) patients were taking opioids, including 23 patients (4%) who had not taken opioids preoperatively. A total of 177 patients (27%) reported surgical site pain, including 45 (13%) patients who had not reported pain preoperatively. The adjusted odds ratio for 3-month opioid use was 18.6 (credible interval, 10.3 to 34.5) for patients who had taken opioids preoperatively. The adjusted odds ratio for 3-month surgical site pain was 2.58 (1.45 to 4.4), 4.1 (1.73 to 8.9), and 2.75 (1.39 to 5.0) for patients who had site pain preoperatively, knee replacement, or spine surgery, respectively. Conclusions: Preoperative opioid use was the strongest predictor of opioid use 3 months postsurgery. None of the other variables showed clinically significant association with opioid use at 3 months after surgery.
UR - http://www.scopus.com/inward/record.url?scp=85152244444&partnerID=8YFLogxK
U2 - 10.1097/ALN.0000000000004510
DO - 10.1097/ALN.0000000000004510
M3 - Article
C2 - 36692360
AN - SCOPUS:85152244444
SN - 0003-3022
VL - 138
SP - 462
EP - 476
JO - Anesthesiology
JF - Anesthesiology
IS - 5
ER -